SkyAI faces shareholder opposition to its 2026 Equity Incentive Plan, which would dilute shares by 7.2%. The company holds $207 million in Solana tokens, far exceeding its $59 million market cap, creating tension over management's strategy. Activist shareholders, including Forward Industries and Bastion Trading, criticize the board for rejecting a buyout offer and adopting a poison pill without shareholder approval. The upcoming September 18 meeting will test if shareholders can influence change despite the board's resistance.
Korn Ferry reported strong Q1 results with earnings per share of $1.43 and revenue of $756.5 million, both exceeding analyst expectations and marking continued growth. Despite this, the stock fell due to conservative guidance for the next quarter, wh...
SailPoint reported Q2 2026 earnings with revenue of $308.81 million, slightly below estimates but up 17% year-over-year. Adjusted EPS of $0.09 beat analyst expectations by 12.5%, reflecting improved profitability. The company showed strong subscripti...
The Cooper Companies is set to report its Q3 2026 earnings with analysts expecting earnings per share (EPS) of $1.12 and revenue of $1.10 billion, both showing growth from the previous year. Despite a recent 2.7% drop in stock price to $67.69, an ana...
Marvel Biosciences Corp. has received approval from the TSX Venture Exchange to extend the closing deadline for its private placement from August 31 to September 14, 2026. The company, which develops synthetic chemical derivatives of off-patent drugs...
Social Security's trust fund is projected to run out by 2032, potentially reducing retirees' benefits and creating an income gap. This shortfall is due to demographic shifts and the program's limited investment options. To supplement future income, r...
